Impact of airflow limitation in chronic heart failure

Impact of airflow limitation in chronic heart failure - ALICE-HF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37787

Enrollment

200

Registered

2012-05-16

Start date

2012-06-22

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

airflow limitation heartfailure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: documented HeartFailure based on left ventricular dysfunction (irrespective of ejection fraction) (following current ESC guidelines) age patients 50 years or older

Exclusion criteria

Exclusion criteria: Patients for whom spiromerty is contra indicated patients with recent surgery, myocardial infarction or cardiac decompensation, lower respiratory tract infection or stroke

Design outcomes

Primary

Measure	Time frame
Airflow limitation (AL), defined as FEV1/FVC	—

Secondary

Measure	Time frame
* Severity of AL, as defined by GOLD stages; * Restrictive AL, defined by FEV1/FVC *0.70 and a predicted FVC	—

Countries

Netherlands

Outcome results